These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9334380)

  • 1. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.
    Doranz BJ; Grovit-Ferbas K; Sharron MP; Mao SH; Goetz MB; Daar ES; Doms RW; O'Brien WA
    J Exp Med; 1997 Oct; 186(8):1395-400. PubMed ID: 9334380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe use of the CXCR4 inhibitor ALX40-4C in humans.
    Doranz BJ; Filion LG; Diaz-Mitoma F; Sitar DS; Sahai J; Baribaud F; Orsini MJ; Benovic JL; Cameron W; Doms RW
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):475-86. PubMed ID: 11350661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.
    Yi Y; Isaacs SN; Williams DA; Frank I; Schols D; De Clercq E; Kolson DL; Collman RG
    J Virol; 1999 Sep; 73(9):7117-25. PubMed ID: 10438797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1.
    Zhou N; Fang J; Acheampong E; Mukhtar M; Pomerantz RJ
    Virology; 2003 Jul; 312(1):196-203. PubMed ID: 12890632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
    J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D; Esté JA; Cabrera C; De Clercq E
    J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.
    Fenard D; Lambeau G; Maurin T; Lefebvre JC; Doglio A
    Mol Pharmacol; 2001 Aug; 60(2):341-7. PubMed ID: 11455021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.
    Tamamura H; Xu Y; Hattori T; Zhang X; Arakaki R; Kanbara K; Omagari A; Otaka A; Ibuka T; Yamamoto N; Nakashima H; Fujii N
    Biochem Biophys Res Commun; 1998 Dec; 253(3):877-82. PubMed ID: 9918823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.
    Lu Z; Berson JF; Chen Y; Turner JD; Zhang T; Sharron M; Jenks MH; Wang Z; Kim J; Rucker J; Hoxie JA; Peiper SC; Doms RW
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6426-31. PubMed ID: 9177234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
    Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
    Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.
    Rucker J; Edinger AL; Sharron M; Samson M; Lee B; Berson JF; Yi Y; Margulies B; Collman RG; Doranz BJ; Parmentier M; Doms RW
    J Virol; 1997 Dec; 71(12):8999-9007. PubMed ID: 9371556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of anti-HIV compounds which interfere the virus entry via coreceptor CXCR4].
    Kanbara K; Fujii N; Nakashima H
    Kansenshogaku Zasshi; 2000 Mar; 74(3):237-44. PubMed ID: 10783578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134.
    Kanbara K; Sato S; Tanuma J; Tamamura H; Gotoh K; Yoshimori M; Kanamoto T; Kitano M; Fujii N; Nakashima H
    AIDS Res Hum Retroviruses; 2001 May; 17(7):615-22. PubMed ID: 11375057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
    Schols D; Struyf S; Van Damme J; Esté JA; Henson G; De Clercq E
    J Exp Med; 1997 Oct; 186(8):1383-8. PubMed ID: 9334378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
    Chabot DJ; Zhang PF; Quinnan GV; Broder CC
    J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection.
    Murakami T; Nakajima T; Koyanagi Y; Tachibana K; Fujii N; Tamamura H; Yoshida N; Waki M; Matsumoto A; Yoshie O; Kishimoto T; Yamamoto N; Nagasawa T
    J Exp Med; 1997 Oct; 186(8):1389-93. PubMed ID: 9334379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.